Femme et Homme
- | Pays :
- Germany
- Norway
- Australia
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to compare the efficacy, safety, pharmacokinetics, and immunogenicity in subjects retreated with visilizumab or placebo after a response in a prior visilizumab study.
Critère d'inclusion
- Ulcerative colitis